{
    "paper_id": "d0e62c5fbf79ff6c1cbdfd3e8748d7a7cb9725c9",
    "metadata": {
        "title": "Journal Pre-proof Supresi\u00f3n de angiotensia II en la infecci\u00f3n por el virus SARS-CoV-2: una propuesta terape\u00fatica Supresi\u00f3n de angiotensia II en la infecci\u00f3n por el virus SARS-CoV-2: una propuesta terape\u00fatica. Angiotensin II suppression in SARS-CoV-2 infection: a therapeutic approach AUTORES",
        "authors": [
            {
                "first": "Jos\u00e9",
                "middle": [],
                "last": "Mar\u00eda",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Lamas-Barreiro",
                "middle": [],
                "last": "Mario",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Alonso-Suarez",
                "middle": [],
                "last": "Jorge",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Juli\u00e1n",
                "middle": [],
                "last": "Fern\u00e1ndez-Mart\u00edn",
                "suffix": "",
                "affiliation": {},
                "email": "jorge.julian.fernandez.martin@sergas.es"
            },
            {
                "first": "Jesus",
                "middle": [
                    "Angel"
                ],
                "last": "Saavedra-Alonso",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Mar\u00eda",
                "middle": [],
                "last": "Lamas-Barreiro",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "J",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Alonso",
                "middle": [],
                "last": "-Suarez",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "M",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Fern\u00e1ndez-Mart\u00edn",
                "middle": [],
                "last": "Jj",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Saavedra-Alonso",
                "middle": [],
                "last": "Ja",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Supresi\u00f3n",
                "middle": [],
                "last": "De Angiotensia",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jos\u00e9",
                "middle": [],
                "last": "Mar\u00eda Lamas-Barreiro",
                "suffix": "",
                "affiliation": {},
                "email": "jose.maria.lamas.barreiro@sergas.es"
            },
            {
                "first": "Mario",
                "middle": [],
                "last": "Alonso-Suarez",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Mario",
                "middle": [],
                "last": "Alonso",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Suarez@sergas",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jorge",
                "middle": [],
                "last": "Es",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Juli\u00e1n Fern\u00e1ndez-Mart\u00edn",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Servicio de Medicina Interna",
                    "location": {}
                },
                "email": ""
            },
            {
                "first": "Jesus",
                "middle": [],
                "last": "Angel",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Saavedra",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Alonso@sergas",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Es",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Espa\u00f1a",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Correspondencia.-Jos\u00e9",
                "middle": [],
                "last": "Mar\u00eda",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Lamas",
                "middle": [],
                "last": "-Barreiro",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "El Sistema Renina Angiotensina (SRA) es un conocido regulador de la funci\u00f3n cardiovascular, implicado en la hipertensi\u00f3n arterial, enfermedad renal, card\u00edaca, arteriosclerosis, diabetes y patolog\u00eda pulmonar 1, 2 . Se ha comprobado que el virus SARS-CoV-2, como otros coronavirus, se introduce en las c\u00e9lulas pulmonares acopl\u00e1ndose a la enzima convertidora de angiotensina II (ECA2) 3, 4 , que forma parte importante del SRA. Esta enzima, expresada en diversos tejidos humanos 5 , parece tener como funci\u00f3n principal mantener el equilibrio entre los efectos vasoconstrictores, proinflamatorios, proliferativos, profibr\u00f3ticos y oxidantes de este sistema y sus antag\u00f3nicos, mediante la degradadaci\u00f3n y disminuci\u00f3n de la producci\u00f3n de angiotensina II y la formaci\u00f3n de angiotensina 1-7 6, 7, 8 (Fig 1) . Parece que la principal regulaci\u00f3n de la ECA2 sobre la angiotensina II ser\u00eda la degradaci\u00f3n directa, puesto que se ha estimado que este efecto es 400 veces mayor que el que tiene sobre la angiotensina I 9 .",
            "cite_spans": [
                {
                    "start": 207,
                    "end": 209,
                    "text": "1,",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 210,
                    "end": 211,
                    "text": "2",
                    "ref_id": null
                },
                {
                    "start": 382,
                    "end": 384,
                    "text": "3,",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 385,
                    "end": 386,
                    "text": "4",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 476,
                    "end": 477,
                    "text": "5",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 782,
                    "end": 784,
                    "text": "6,",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 785,
                    "end": 787,
                    "text": "7,",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 788,
                    "end": 789,
                    "text": "8",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 790,
                    "end": 797,
                    "text": "(Fig 1)",
                    "ref_id": null
                }
            ],
            "section": ""
        },
        {
            "text": "En los \u00faltimos a\u00f1os se han publicado distintos estudios sobre los posibles efectos beneficiosos que podr\u00eda tener la ECA2 a nivel cardiovascular, renal y pulmonar 10, 11, 12, 13 , que se han relacionados con su efecto supresor de la angiotensina II. Imai et al 13 observaron que la Angiotensina II empeoraba el distress respiratorio en distintos modelos experimentales y que esta mala evoluci\u00f3n mejoraba con el bloqueo del receptor 1 de de la angiotensina II (AT1). Tambi\u00e9n observaron que la evoluci\u00f3n era peor si se produc\u00eda un descenso en la expresi\u00f3n de ECA2, como suced\u00eda en las infecciones por coronavirus, argumentando que esta evoluci\u00f3n desfavorable ser\u00eda debida en parte a un descenso de la regulaci\u00f3n de la angiotensina II por esta enzima.",
            "cite_spans": [
                {
                    "start": 162,
                    "end": 165,
                    "text": "10,",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 166,
                    "end": 169,
                    "text": "11,",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 170,
                    "end": 173,
                    "text": "12,",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 174,
                    "end": 176,
                    "text": "13",
                    "ref_id": "BIBREF12"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "J o u r n a l P r e -p r o o f infectados por estos virus 13 . Se ha propuesto tambien que los IECA podr\u00edan alterar en parte la estructura de la enzima por su similitud con la ECA, dificultando tambi\u00e9n as\u00ed la adhesi\u00f3n del virus 5 .",
            "cite_spans": [
                {
                    "start": 58,
                    "end": 60,
                    "text": "13",
                    "ref_id": "BIBREF12"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Con respecto a los cuadros clinicos m\u00e1s severos, los datos son m\u00e1s contradictorios, puesto que est\u00e1 descrito que el descenso de la actividad de la ECA2, ocasionada por el virus, podr\u00eda aumentar la lesi\u00f3n pulmonar, aunque en estas circunstancias el posible beneficio de la ECA2 podr\u00eda deberse a que aumenta la degradaci\u00f3n de la angiotensina II, que estar\u00eda elevada por un defecto en su regulaci\u00f3n y un aumento de la actividad de la renina estimulado por la hipoxia. Estos cuadros, que afectan a entre un 5 y un 10% de los pacientes con infecci\u00f3n por SARS-CoV-2, se caracterizan por una inflamaci\u00f3n aguda devastadora con expresi\u00f3n pulmonar predominante (neumon\u00edas, hipoxia y distress respiratorio grave) y probablemente est\u00e1n relacionados con diferentes expresiones de interfer\u00f3n, patrones de citoquinas y otros mecanismos moleculares desconocidos, que explicar\u00edan las diferentes presentaciones cl\u00ednicas, independientemente de la edad de los pacientes 23 .",
            "cite_spans": [
                {
                    "start": 950,
                    "end": 952,
                    "text": "23",
                    "ref_id": "BIBREF24"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Es interesante resaltar que hay diferencias inter-individuales en la conformaci\u00f3n de la ECA y de sus efectores acompa\u00f1antes. Distintos estudios han mostrado la importancia farmacogen\u00f3mica de las tres variantes de sintetasas endoteliales de \u00f3xido N\u00edtrico (eNOS) sobre las respuestas de la inhibici\u00f3n de la ECA. La variabilidad gen\u00e9tica de los genes eNOS o de los genes que contribuyen a su activaci\u00f3n podr\u00eda afectar la respuesta de los IECA. Uno de estos estudios se ha centrado en pacientes hipertensos tratados con el IECA enalapril 24 .",
            "cite_spans": [
                {
                    "start": 534,
                    "end": 536,
                    "text": "24",
                    "ref_id": "BIBREF25"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Los efectos beneficiosos de la inhibici\u00f3n de la ECA a nivel pulmonar se han demostrado en diversos estudios, tanto a nivel experimental -efecto antiinflamatorio del enalapril en un modelo animal de toxicidad pulmonar inducida 25 y del perindopril, otro IECA, en la afectaci\u00f3n pulmonar secundaria a sepsis 26 -como cl\u00ednico, metaan\u00e1lisis en el que se observa un efecto protector de los IECA en el riesgo de neumon\u00edas 27 .",
            "cite_spans": [
                {
                    "start": 415,
                    "end": 417,
                    "text": "27",
                    "ref_id": "BIBREF28"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "El efecto cl\u00ednico de los IECAs y ARA II en pacientes con COVID-19, que precisan ingreso hospitalario, est\u00e1 siendo evaluado en un estudio en marcha en el King's College Hospital and Princess Royal University Hospital de Londres 28 . En sus resultados preliminares no observan una peor evoluci\u00f3n en los pacientes tratados con IECAs con respecto a los que no toman estos f\u00e1rmacos, e incluso apuntan a que parecen tener una evoluci\u00f3n m\u00e1s favorable. Con respecto a los ARAII, todav\u00eda no han podido extraer conclusiones por el escaso n\u00famero de casos analizado.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Independientemente de otras opciones terape\u00faticas m\u00e1s espec\u00edficas: antivirales, bloqueo directo de la ECA2, tratamiento con ECA2 recombinante para intentar saturar la capacidad de uni\u00f3n del virus al mismo, vacunas y otros 29,30 , la opci\u00f3n propuesta deber\u00eda ser considerada porque se trata de una terapia muy conocida, accesible y segura, si se administra de forma controlada, que podr\u00eda ayudarnos a reducir la extensi\u00f3n y los efectos de la infecci\u00f3n.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "En una primera fase, ser\u00eda necesario, como comentan otros autores 13, 18 , analizar lo antes posible los datos epidemiol\u00f3gicos disponibles de los pacientes infectados, respecto a su evoluci\u00f3n e historial de toma de f\u00e1rmacos antihipertensivos, pero simult\u00e1neamente ser\u00eda conveniente plantear estudios prospectivos aleatorizados en las infecciones iniciales en los que una de las ramas incluya, adem\u00e1s del tratamiento considerado m\u00e1s idoneo para cada caso, la asociaci\u00f3n de un IECA, con un control cl\u00ednico estricto de estos pacientes, en la linea de los ya iniciados por otros investigadores.",
            "cite_spans": [
                {
                    "start": 66,
                    "end": 69,
                    "text": "13,",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 70,
                    "end": 72,
                    "text": "18",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Es necesario continuar desarrollando la investigaci\u00f3n encaminada a mejorar el conocimiento sobre la correlaci\u00f3n existente entre los niveles de angiotensina II y la actividad de la ECA2 en distintos tejidos: pulmonar, card\u00edaco y renal, puesto que parece que el grado de actividad de los componentes del SRA pueden variar entre distintos \u00f3rganos y con respecto a los niveles plasm\u00e1ticos. Adem\u00e1s deber\u00e1 aclararse si el posible efecto beneficioso descrito con los niveles m\u00e1s altos de ECA2 se deben a una mayor degradaci\u00f3n de la angiotensina II y aumento de angiotensina 1-7 o a una acci\u00f3n a trav\u00e9s de otras v\u00edas metab\u00f3licas.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Consideramos tambi\u00e9n que es muy importante disponer los antes posible de resultados de estudios reglados y sistematizados sobre los efectos del bloqueo de la angiotensina II u otros componentes del SRA en la infecci\u00f3n por SARS-CoV-2, puesto que la falta de evidencia cient\u00edfica sobre esta cuesti\u00f3n est\u00e1 haciendo que prolifere una gran cantidad de literatura cient\u00edfica con opiniones muy dispares sobre los posibles efectos de los farmacos que interfieren con este sistema, basadas solo en estudios experimentales con muchas limitaciones, como algunos de los ya referidos, y en interpretaciones subjetivas 31, 32 ; llegando incluso a proponerse formalmente, creemos que de forma precipitada, actuaciones contrarias al posicionamiento de la sociedades cient\u00edficas y la agencia europea del medicamento sobre la utilizaci\u00f3n de estos medicamentos en caso de afectaci\u00f3n por COVID-19 33 .",
            "cite_spans": [
                {
                    "start": 605,
                    "end": 608,
                    "text": "31,",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 609,
                    "end": 611,
                    "text": "32",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 877,
                    "end": 879,
                    "text": "33",
                    "ref_id": "BIBREF35"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "A la Dr. Sara Lamas-Alvarez por sus interesantes sugerencias y aportaciones para mejorar la redacci\u00f3n y comprensi\u00f3n del manuscrito. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Agradecimientos.-"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "-Tikellis",
                    "suffix": ""
                },
                {
                    "first": "Thomas",
                    "middle": [],
                    "last": "Mc",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Int J Pept",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1155/2012/256294"
                ]
            }
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "N"
                    ],
                    "last": "Van Buren",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Toto",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Adv Chronic Kidney Dis",
            "volume": "18",
            "issn": "1",
            "pages": "28--41",
            "other_ids": {
                "DOI": [
                    "10.1053/j.ackd.2010.10.003"
                ]
            }
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Shang",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Graham",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J. Virol",
            "volume": "94",
            "issn": "7",
            "pages": "127--147",
            "other_ids": {
                "DOI": [
                    "10.1128/JVI.00127-20"
                ]
            }
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "-Yan",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Science",
            "volume": "367",
            "issn": "6485",
            "pages": "1444--1448",
            "other_ids": {
                "DOI": [
                    "10.1126/science.abb2762"
                ]
            }
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Structure analysis of the receptor binding of 2019-nCoV",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "-Chen",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Pan",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "J"
                    ],
                    "last": "Zhao",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Biochem Biophys Res Commun",
            "volume": "pii",
            "issn": "20",
            "pages": "30339--30348",
            "other_ids": {
                "DOI": [
                    "10.1016/j.bbrc.2020.02.071"
                ]
            }
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Enzima conversiva de la angiotensina 2 y su papel emergente en la regulaci\u00f3n del sistema renina-angiotensina",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "-Soler",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lloverasa",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Batlleb",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Med. Clin",
            "volume": "131",
            "issn": "6",
            "pages": "230--236",
            "other_ids": {
                "DOI": [
                    "10.1157/13124619"
                ]
            }
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "El sistema renina-angiotensina: \u00bfhasta d\u00f3nde se expande?, \u00bfes posible bloquearlo?",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "-Nieto",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "R"
                    ],
                    "last": "Robles",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Li\u00e9bana",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Nefrologia Sup Ext",
            "volume": "2",
            "issn": "5",
            "pages": "48--56",
            "other_ids": {
                "DOI": [
                    "10.3265/NefrologiaSuplementoExtraordinario.pre2011.Jul.11073"
                ]
            }
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Hern\u00e1ndez-Hern\u00e1ndez H El sistema renina-angiotensina-aldosterona y su papel funcional m\u00e1s all\u00e1 del control de la presi\u00f3n arterial",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Santeliz-Contra",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Romano-Estrada",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gonz\u00e1lez-Ch\u00e1vez",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Rev. Mex. Cardiol",
            "volume": "19",
            "issn": "1",
            "pages": "21--29",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Hydrolysis of Biological Peptides by Human Angiotensinconverting Enzyme-related Carboxypeptidase",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Vickers",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Hales",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Kaushik",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J. Biol. Chem",
            "volume": "277",
            "issn": "",
            "pages": "14838--14843",
            "other_ids": {
                "DOI": [
                    "10.1074/jbc.M200581200"
                ]
            }
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "-Ramchand",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "K"
                    ],
                    "last": "Patel",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Piyush",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "PLoS One",
            "volume": "13",
            "issn": "6",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1371/journal.pone.0198144"
                ]
            }
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Targeting the Degradation of Angiotensin II with Recombinant ACE2: Prevention of Angiotensin II-dependent hypertension",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "-Wysocki",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ye",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Rodriguez",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Hypertension",
            "volume": "55",
            "issn": "1",
            "pages": "90--98",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Angiotensin-Converting Enzyme II in the Heart and the Kidney",
            "authors": [
                {
                    "first": "U",
                    "middle": [],
                    "last": "Danilczyk",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Josef",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Penninger",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Circ Res",
            "volume": "98",
            "issn": "",
            "pages": "463--471",
            "other_ids": {
                "DOI": [
                    "10.1161/01.RES.0000205761.22353.5f"
                ]
            }
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Angiotensin-converting enzyme 2 in acute respiratory distress syndrome",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "-Imai",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kuba",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Penninger",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Cell. Mol. Life Sci",
            "volume": "64",
            "issn": "",
            "pages": "2006--2012",
            "other_ids": {
                "DOI": [
                    "10.1007/s00018-007-6228-6"
                ]
            }
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "-Gurwitz",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Drug Dev Res",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1002/ddr.21656"
                ]
            }
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "P"
                    ],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "H"
                    ],
                    "last": "Su",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Chin J Tuberc Respr Dis",
            "volume": "43",
            "issn": "3",
            "pages": "219--222",
            "other_ids": {
                "DOI": [
                    "10.3760/cma.j.issn.1001-0939.2020.03.016"
                ]
            }
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Use of angiotensin receptor blockers such as Telmisartan, Losartsan in nCoV Wuhan CoronaVirus infections-Novel mode of treatment. Rapid response to: The emerging novel coronavirus outbreak",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "-Phadke",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Saunik",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "BMJ",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1136/bmj.m406"
                ]
            }
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Gu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Sci Rep",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1038/srep07027"
                ]
            }
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "C"
                    ],
                    "last": "Chappell",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Circulation",
            "volume": "111",
            "issn": "20",
            "pages": "2605--2610",
            "other_ids": {
                "DOI": [
                    "10.1161/CIRCULATIONAHA.104.510461"
                ]
            }
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "ACE inhibitors as a potential risk factor for fatal Covid-19. Rapid response to: Preventing a covid-19 pandemic",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Sommerstein",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Gr\u00e4ni",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "BMJ",
            "volume": "368",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1136/bmj.m810"
                ]
            }
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "E"
                    ],
                    "last": "-Walters",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Kalman",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "K"
                    ],
                    "last": "Patel",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Europace",
            "volume": "19",
            "issn": "8",
            "pages": "1280--1287",
            "other_ids": {
                "DOI": [
                    "10.1093/europace/euw246"
                ]
            }
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "-Zhou",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "9",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/S0140-6736(20)30566-3"
                ]
            }
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "COVID-19 and the cardiovascular system",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ma",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nat Rev Cardiol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1038/s41569-020-0360-5"
                ]
            }
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Conti",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Ronconi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Caraffa",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Biol Regul Homeost Agents",
            "volume": "34",
            "issn": "2",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.23812/CONTI-E"
                ]
            }
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "S"
                    ],
                    "last": "-Silva",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Fontana",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Luizon",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Eur J Clin Pharmacol",
            "volume": "69",
            "issn": "2",
            "pages": "167--77",
            "other_ids": {
                "DOI": [
                    "10.1007/s00228-012-1326-2"
                ]
            }
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Effects of enalapril on IL-1beta, IL-6 expression in rat lung exposure to acrolein",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "L"
                    ],
                    "last": "-Wang",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [
                        "Q"
                    ],
                    "last": "Dan",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "Y"
                    ],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "L"
                    ],
                    "last": "Meng",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "H"
                    ],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Journal of Sichuan University. Medical science edition",
            "volume": "41",
            "issn": "6",
            "pages": "1003--1007",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "The protective effects of angiotensin-converting enzyme inhibitor against cecal ligation and puncture-induced sepsis via oxidative stress and inflammation",
            "authors": [
                {
                    "first": "U",
                    "middle": [],
                    "last": "Kostakoglu",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Topcu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Atak",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Life Sci",
            "volume": "241",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.lfs.2019.117051"
                ]
            }
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Caldeira",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Alarc\u00e3o",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Vaz-Carneiro",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Costa",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "BMJ",
            "volume": "345",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Treatment with ACE-inhibitors is associated with less severe disease with SARS-Covid-19 infection in a multi-site UK acute Hospital Trust",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "-Bean",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Kraljevic",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Searle",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Kruse",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "9",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "-Zhang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Penninger",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Zhong",
                    "suffix": ""
                },
                {
                    "first": "Arthur",
                    "middle": [
                        "S"
                    ],
                    "last": "Slutsky",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Intensive Care Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1007/s00134-020-05985-9"
                ]
            }
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Interaction between RAAS inhibitors and ACE2 in the context of COVID-19",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "-Mourad",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "I"
                    ],
                    "last": "Levy",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nat. Rev. Cardiol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1038/s41569-020-0368-x"
                ]
            }
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Reply to: 'Interaction between RAAS inhibitors and ACE2 in the context of COVID-19'",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "Y"
                    ],
                    "last": "-Zheng",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "T"
                    ],
                    "last": "Ma",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "Y"
                    ],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Xie",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nat. Rev. Cardiol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Drugs and the renin-angiotensin system in covid-19",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "K"
                    ],
                    "last": "Aronson",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "E"
                    ],
                    "last": "Ferner",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "BMJ",
            "volume": "369",
            "issn": "2",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1136/bmj.m1313"
                ]
            }
        }
    },
    "ref_entries": {
        "TABREF0": {
            "text": "Figura 1.-Esquema del Sistema Renina Angiotensina. ECA: Enzima convertidora de Angiotensina; ECA2: Enzima convertidora de Angiotensina II; IECA: Inhibidor de la ECA; ARAII: Antagonista del Receptor AT1 AT1: Receptor 1 de Angiotensina II; AT2: Receptor 2 de Angiotensina II; MAS: Receptor de ensamblaje mitocondrial.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}